Is Inspire Medical Systems (INSP) overvalued or fairly valued?

MarketChacha shows Inspire Medical Systems's valuation in context — a forward P/E of about 39.9, a price-to-book of about 1.8 — alongside its revenue and profit growth and whether reported profit converts into operating cash, so you can judge value for yourself. MarketChacha does not issue ratings, price targets, or buy/sell advice.

Does Inspire Medical Systems's reported profit turn into cash?

Over 3 years, operating cash flow fully covered reported profit — earnings are backed by real cash. MarketChacha computes this cash-conversion check (1.53×) from reported figures — education, not a rating.

What is Inspire Medical Systems's revenue?

Inspire Medical Systems reported revenue of $912.0M for FY2025, with net profit of $145.4M, per official filings.

What is the share price of Inspire Medical Systems (INSP)?

Inspire Medical Systems last traded at $50.37 (-4.0% on the day), as of 7/22/2026 — a delayed quote shown for education, not investment advice.

Inspire Medical Systems

INSP · NYSE · Healthcare · United States

$50.37-4.0%

Delayed · as reported by Yahoo Finance · as of Jul 22, 2026, 7:31 PM

Snapshot

TickerINSP

ExchangeNYSE

SectorHealthcare

IndustryMedical Devices

CountryUnited States

Employees1,333

HeadquartersGolden Valley, United States

Market cap$1.5B

P/B1.8

Volume328.28K

Websitewww.inspiresleep.com

Filings tracked5

About Inspire Medical Systems

Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for patients with moderate to severe OSA. It also develops a novel, closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.

Profile as reported by Yahoo Finance.

Who owns it

Insiders1.1%
Institutions98.9%
Public & other0.0%

414 institutional holders

As reported by Yahoo Finance.

Top holders

Blackrock Inc.12.32%
Deerfield Management Company, L.P9.38%
Wellington Management Group, LLP8.80%
Vanguard Portfolio Management LLC5.68%
Morgan Stanley5.03%
Vanguard Capital Management LLC4.40%
Shaw D.E. & Co., Inc.4.12%
William Blair Investment Management, LLC3.95%

Largest institutional holders, as reported by Yahoo Finance (as of 3/31/2026).

Forensic scorecard

No major accounting red flags in the fundamentals we have — profit is backed by cash and returns look healthy.

Cash conversion1.53×

Over 3 years, operating cash flow fully covered reported profit — earnings are backed by real cash.

Net margin trend-3.4% → 15.9%

Margin has expanded by about 19.3 points — the business is getting more profitable.

Return on equity18.6%

Latest ROE of 18.6% — capital is generating a healthy return.

Computed by MarketChacha from reported figures (SEC XBRL). Education, not a rating or recommendation.

What's expected next

Next quarter

Rev $203.0M · EPS 0.13

Est. earnings growth -65.6%

Next fiscal year

Rev $875.6M · EPS 1.26

Est. earnings growth +39.8%

Analyst consensus estimates — not the company's own guidance. As reported by Yahoo Finance.

$38.9152-wk range$147.03

Delayed · as reported by Yahoo Finance

New to these terms?

P/E ROE ROCE Margins Market cap

Browse the Learn hub →

Financials at a glance

Source: SEC XBRL

Annual

Quarterly · last 8

Market cap

$1.5B

Day change

-4.0%

Fwd P/E

39.9

P/B

1.8

Beta

0.71

Revenue (FY2025)

$912.0M

Net margin

15.9%

ROE

18.6%

Revenue CAGR (2y)

+20.8%

EPS (FY2025)

4.89

Net profit (FY2025)

$145.4M

Market figures: Delayed · as reported by Yahoo Finance. Financials as reported in company filings.

Ask MarketChacha about INSP

Get a cited, plain-English answer — the “why”, not just data. Finance research only, never buy/sell advice.

Financials

Yearly

Period	Revenue	Net profit	EPS	Net margin	ROE
FY2025	$912.0M	$145.4M	4.89	15.9%	18.6%
FY2024	$802.8M	$53.5M	1.75	6.7%	7.8%
FY2023	$624.8M	$-21.2M	-0.72	-3.4%	-3.7%

Quarterly

Period	Revenue	Net profit	EPS	Net margin
2026Q1	$204.6M	$-11.3M	-0.39	-5.5%
2025Q3	$224.5M	$9.9M	0.34	4.4%
2025Q2	$217.1M	$-3.6M	-0.12	-1.7%
2025Q1	$201.3M	$3.0M	0.10	1.5%
2024Q3	$203.2M	$18.5M	0.60	9.1%
2024Q2	$195.9M	$9.8M	0.32	5.0%
2024Q1	$164.0M	$-10.0M	-0.34	-6.1%
2023Q3	$153.3M	$-8.5M	-0.29	-5.6%
2023Q2	$151.1M	$-12.0M	-0.41	-7.9%
2023Q1	$127.9M	$-15.4M	-0.53	-12.1%

Figures as reported, in reporting currency. Source: SEC XBRL.

Filings & announcements

2026

8-K — Executive/director change, Exhibits
SEC7/22/2026material
8-K — Reg FD disclosure, Exhibits
SEC6/26/2026material
8-K — Executive/director change, Bylaw/charter change, Shareholder vote results, Exhibits
SEC5/5/2026material
8-K — Results of operations, Reg FD disclosure, Exhibits
SEC5/4/2026material
10-Q filing
SEC5/4/2026

In the news

Education and discussion only — not investment advice. Financials from official filings (SEC/BSE) and reported company statements; market figures (delayed · as reported by yahoo finance) are delayed and shown for reference only. Verify with the linked sources before acting.